Michael G. Kaplitt, MD, PhD

I am a neurosurgeon with clinical activities focused upon the usage of minimally invasive, stereotactic techniques for the treatment of functional disorders such as Parkinson's disease, essential tremor, and epilepsy. I also use surgical methods to implant devices such as spinal cord stimulators and opiate pumps to treat complex pain, and I am a expert in the treatment of trigeminal neuralgia and hydrocephalus.

I have pioneered the use of gene therapy in the brain and have published more than 40 papers and edited two books on this subject. I recently completed the first clinical trial of gene therapy for Parkinson's disease for FDA approval, and my laboratory is actively researching mechanisms of cell death in diseases such as Parkinson's and Huntington's.

I am the recipient of numerous awards, including the Young Investigator Award from the American Society for Gene Therapy and was named to Crain's “40 under 40” list for 2004. I currently serve on the editorial boards of several journals, and am the editor for the Web site of the World Society for Stereotactic and Functional Neurosurgery. I am also a member of the Committee on Admissions at Weill Cornell Medical College and am an adjunct professor at The Rockefeller University.

Appointments for New Patients
Clinical Expertise

Molecular Medicine; Movement Disorders; Spinal Opiate Catheter Implants; Spinal Cord Stimulator Implants; Parkinson’s Disease; Trigeminal Neuralgia Surgery

Languages Spoken

MD, Weill Cornell Medical College; PhD, The Rockefeller University


NewYork-Presbyterian Hospital/Weill Cornell Medical Center


University of Toronto (Canada); The Rockefeller University

Board Certifications

Neurological Surgery

See My Colleagues in:
Publications by Michael G. Kaplitt
Visit PubMed for full listing of Michael G. Kaplitt journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.